Skip to main content
Top
Published in: Dysphagia 1/2022

01-02-2022 | Gastroesophageal Reflux Disease | Original Article

Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry

Authors: Shumon I. Dhar, Nogah Nativ-Zeltzer, Omid B. Mehdizadeh, Apoorva T. Ramaswamy, Yuval Nachalon, Peter C. Belafsky

Published in: Dysphagia | Issue 1/2022

Login to get access

Abstract

Weak or absent peristalsis of the esophageal musculature is a common finding in ambulatory patients suffering from dysphagia and frequently associated with gastroesophageal reflux. There is currently no pharmacologic intervention that reliably improves esophageal contractility in patients suffering from various esophageal motility disorders. Our objective was to evaluate the acute effects of pyridostigmine on high-resolution manometry parameters in patients suffering from dysphagia with evidence of esophageal dysmotility. Pyridostigmine is an acetylcholinesterase inhibitor which increases effective concentrations of acetylcholine at the neuromuscular junction of both striated and smooth muscle cells. We conducted a prospective crossover study of five patients with dysphagia and proven esophageal dysmotility. Three patients had baseline ineffective esophageal motility and two had achalasia. Patients underwent pharyngeal and esophageal manometry before and after pyridostigmine administration. The median distal contractile integral (DCI), a marker of esophageal contractile vigor, was significantly higher post pyridostigmine administration 3001 (1950.3–3703.2) mmHg × s × cm compared to pre-pyridostigmine DCI of 1229.9 (956.2–2100) mmHg × s × cm; P < 0.001. Pre-pyridostigmine 18/25 (72%) of the patient’s swallows was peristaltic compared to 25/25 (100%) post-pyridostigmine; P < 0.005. No other pharyngeal or esophageal high-resolution manometry parameter differed significantly after pyridostigmine administration. The results of this pilot study demonstrate that pyridostigmine acutely improves esophageal contractile vigor in patients suffering from dysphagia with esophageal dysmotility. Further investigation with larger sample size, longer follow-up, side effect profile, and patient-reported outcome measures is still needed to determine the clinical usefulness of pyridostigmine in specific disorders of esophageal motility.
Literature
1.
go back to reference Ashraf HH, Palmer J, Dalton HR, Waters C, Luff T, Strugnell M, et al. Can patients determine the level of their dysphagia? World J Gastroenterol. 2017;23:1038–43.CrossRef Ashraf HH, Palmer J, Dalton HR, Waters C, Luff T, Strugnell M, et al. Can patients determine the level of their dysphagia? World J Gastroenterol. 2017;23:1038–43.CrossRef
2.
go back to reference Roeder BE, Murray JA, Dierkhising RA. Patient localization of esophageal dysphagia. Dig Dis Sci. 2004;49:697–701.CrossRef Roeder BE, Murray JA, Dierkhising RA. Patient localization of esophageal dysphagia. Dig Dis Sci. 2004;49:697–701.CrossRef
3.
go back to reference Nouraei S a. R, Murray IA, Heathcote KJ, Dalton HR. Oesophageal causes of dysphagia localised only to the pharynx: Implications for the suspected head and neck cancer pathway. Clin Otolaryngol. 2018; Nouraei S a. R, Murray IA, Heathcote KJ, Dalton HR. Oesophageal causes of dysphagia localised only to the pharynx: Implications for the suspected head and neck cancer pathway. Clin Otolaryngol. 2018;
4.
go back to reference Gyawali CP, Sifrim D, Carlson DA, Hawn M, Katzka DA, Pandolfino JE, et al. Ineffective esophageal motility: concepts, future directions, and conclusions from the Stanford 2018 symposium. Neurogastroenterol Motil. 2019;31:e13584.CrossRef Gyawali CP, Sifrim D, Carlson DA, Hawn M, Katzka DA, Pandolfino JE, et al. Ineffective esophageal motility: concepts, future directions, and conclusions from the Stanford 2018 symposium. Neurogastroenterol Motil. 2019;31:e13584.CrossRef
5.
go back to reference Jain A, Baker JR, Chen JW. In ineffective esophageal motility, failed swallows are more functionally relevant than weak swallows. Neurogastroenterol Motil. 2018;30:e13297.CrossRef Jain A, Baker JR, Chen JW. In ineffective esophageal motility, failed swallows are more functionally relevant than weak swallows. Neurogastroenterol Motil. 2018;30:e13297.CrossRef
6.
go back to reference Hollenstein M, Thwaites P, Bütikofer S, Heinrich H, Sauter M, Ulmer I, et al. Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders. Lancet Gastroenterol Hepatol. 2017;2:644–53.CrossRef Hollenstein M, Thwaites P, Bütikofer S, Heinrich H, Sauter M, Ulmer I, et al. Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders. Lancet Gastroenterol Hepatol. 2017;2:644–53.CrossRef
7.
go back to reference Ho S-C, Chang C-S, Wu C-Y, Chen G-H. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47:652–6.CrossRef Ho S-C, Chang C-S, Wu C-Y, Chen G-H. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47:652–6.CrossRef
9.
go back to reference Mashimo H, Goyal RK. Physiology of esophageal motility. GI motility online [internet]. Berlin: Nature Publishing Group; 2006. Mashimo H, Goyal RK. Physiology of esophageal motility. GI motility online [internet]. Berlin: Nature Publishing Group; 2006.
10.
go back to reference Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43:253–60.CrossRef Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43:253–60.CrossRef
11.
go back to reference Belafsky PC, Kuhn M. The clinician’s guide to swallowing fluoroscopy [internet]. New York: Springer; 2014. Belafsky PC, Kuhn M. The clinician’s guide to swallowing fluoroscopy [internet]. New York: Springer; 2014.
12.
go back to reference Kahrilas PJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.CrossRef Kahrilas PJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.CrossRef
13.
go back to reference Arffa RE, Krishna P, Gartner-Schmidt J, Rosen CA. Normative values for the voice handicap index-10. J Voice. 2012;26:462–5.CrossRef Arffa RE, Krishna P, Gartner-Schmidt J, Rosen CA. Normative values for the voice handicap index-10. J Voice. 2012;26:462–5.CrossRef
14.
go back to reference Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, et al. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117:919–24.CrossRef Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, et al. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117:919–24.CrossRef
15.
go back to reference Crary MA, Mann GDC, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86:1516–20.CrossRef Crary MA, Mann GDC, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005;86:1516–20.CrossRef
16.
go back to reference Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16:274–7.CrossRef Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16:274–7.CrossRef
17.
go back to reference Maggi L, Mantegazza R. Treatment of myasthenia gravis: focus on pyridostigmine. Clin Drug Investig. 2011;31:691–701.CrossRef Maggi L, Mantegazza R. Treatment of myasthenia gravis: focus on pyridostigmine. Clin Drug Investig. 2011;31:691–701.CrossRef
18.
go back to reference Omari TI, Ciucci M, Gozdzikowska K, Hernández E, Hutcheson K, Jones C, et al. High-resolution pharyngeal manometry and impedance: protocols and metrics-recommendations of a high-resolution pharyngeal manometry international working group. Dysphagia. 2020;35:281–95.CrossRef Omari TI, Ciucci M, Gozdzikowska K, Hernández E, Hutcheson K, Jones C, et al. High-resolution pharyngeal manometry and impedance: protocols and metrics-recommendations of a high-resolution pharyngeal manometry international working group. Dysphagia. 2020;35:281–95.CrossRef
19.
go back to reference Leonard R, Rees CJ, Belafsky P, Allen J. Fluoroscopic surrogate for pharyngeal strength: the pharyngeal constriction ratio (PCR). Dysphagia. 2011;26:13–7.CrossRef Leonard R, Rees CJ, Belafsky P, Allen J. Fluoroscopic surrogate for pharyngeal strength: the pharyngeal constriction ratio (PCR). Dysphagia. 2011;26:13–7.CrossRef
20.
go back to reference Roman S, Kahrilas PJ, Mion F, Nealis TB, Soper NJ, Poncet G, et al. Partial recovery of peristalsis after myotomy for achalasia; more the rule than the exception. JAMA Surg. 2013;148:157–64.CrossRef Roman S, Kahrilas PJ, Mion F, Nealis TB, Soper NJ, Poncet G, et al. Partial recovery of peristalsis after myotomy for achalasia; more the rule than the exception. JAMA Surg. 2013;148:157–64.CrossRef
21.
go back to reference Goyal RK, Chaudhury A. Physiology of normal esophageal motility. J Clin Gastroenterol. 2008;42:610–9.CrossRef Goyal RK, Chaudhury A. Physiology of normal esophageal motility. J Clin Gastroenterol. 2008;42:610–9.CrossRef
22.
go back to reference O’Rourke A, Weinberger P, Morrison M, Conklin J, Postma G. Topical bethanechol for the improvement of esophageal dysmotility: a pilot study: annals of otology, rhinology & laryngology [internet]. Los Angeles, CA: SAGE; 2013. O’Rourke A, Weinberger P, Morrison M, Conklin J, Postma G. Topical bethanechol for the improvement of esophageal dysmotility: a pilot study: annals of otology, rhinology & laryngology [internet]. Los Angeles, CA: SAGE; 2013.
23.
Metadata
Title
Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry
Authors
Shumon I. Dhar
Nogah Nativ-Zeltzer
Omid B. Mehdizadeh
Apoorva T. Ramaswamy
Yuval Nachalon
Peter C. Belafsky
Publication date
01-02-2022
Publisher
Springer US
Published in
Dysphagia / Issue 1/2022
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-020-10243-7

Other articles of this Issue 1/2022

Dysphagia 1/2022 Go to the issue